Nitric oxide in inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 9, Issue 3, 2003, Pages 179-189

  Cross, Raymond K ^a   Wilson, Keith T ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Animal models; Colitis; Epithelium; Inducible nitric oxide synthase

Indexed keywords

ARGINASE; ARGININE; FREE RADICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; ORNITHINE DECARBOXYLASE; POLYAMINE;

BIOCHEMISTRY; CLINICAL STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFECT; ENTERITIS; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME SYNTHESIS; HUMAN; INTESTINE MUCOSA; MEDICAL ASSESSMENT; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SYNTHESIS; TREATMENT OUTCOME; ULCERATIVE COLITIS; UPREGULATION;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 0038392976     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200305000-00006     Document Type: Review

References (126)

1. Wilson KT, Vaandrager AB, de Vente J, et al. Production and localization of cGMP and PGE2 in nitroprusside-stimulated rat colonic ion transport. Am J Physiol 1996;270(Cell Physiol 39):C832-40.
2. Stuehr DJ, Marletta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci U S A 1985; 82:7738-42.
3. Xie QW, Cho HJ, Calaycay J, et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992;256:225-8.
4. Tepperman BL, Brown JF, Whittle BJ. Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am J Physiol 1993;265:G214-8.
5. Asano K, Chee CB, Gaston B, et al. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci U S A 1994;91: 10089-93.
6. Brown JF, Keates AC, Hanson PJ, et al. Nitric oxide generators and cGMP stimulate mucus secretion by rat gastric mucosal cells. Am J Physiol 1993;265:G418-22.
7. Price KJ, Hanson PJ, Whittle BJ. Stimulation by carbachol of mucus gel thickness in rat stomach involves nitric oxide. Eur J Pharmacol 1994;263:199-202.
8. Wilson KT, Xie Y, Musch MW, et al. Sodium nitroprusside stimulates anion secretion and inhibits sodium chloride absorption in rat colon. J Pharmacol Exp Ther 1993;266:224-30.
9. MacNaughton WK. Nitric oxide-donating compounds stimulate electrolyte transport in the guinea pig intestine in vitro. Life Sci 1993;53:585-93.
10. Tamai H, Gaginella TS. Direct evidence for nitric oxide stimulation of electrolyte secretion in the rat colon. Free Radic Res Commun 1993;19:229-39.
11. MacNaughton WK, Lowe SS, Cushing K. Role of nitric oxide in inflammation-induced suppression of secretion in a mouse model of acute colitis. Am J Physiol 1998;275:G1353-60.
12. Asfaha S, Bell CJ, Wallace JL, et al. Prolonged colonic epithelial hyporesponsiveness after colitis: role of inducible nitric oxide synthase. Am J Physiol 1999;276:G703-10.
13. Menconi MJ, Unno N, Smith M, et al. Nitric oxide donor-induced hyperpermeability of cultured intestinal epithelial monolayers: role of superoxide radical, hydroxyl radical, and peroxynitrite. Biochim Biophys Acta 1998;1425:189-203.
14. Madara JL, Stafford J. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1989;83:724-7.
15. Sugi K, Musch MW, Field M, et al. Inhibition of Na+,K+-ATPase by interferon gamma downregulates intestinal epithelial transport and barrier function. Gastroenterology 2001;120:1393-403.
16. Chavez AM, Menconi MJ, Hodin RA, et al. Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide. Crit Care Med 1999;27:2246-51.
17. Pique JM, Whittle BJ, Esplugues JV. The vasodilator role of endogenous nitric oxide in the rat gastric microcirculation. Eur J Pharmacol 1989;174:293-6.
18. Holzer P, Sametz W. Gastric mucosal protection against ulcerogenic factors in the rat mediated by capsaicin-sensitive afferent neurons. Gastroenterology 1986;91:975-81.
19. Lippe IT, Holzer P. Participation of endothelium-derived nitric oxide but not prostacyclin in the gastric mucosal hyperaemia due to acid back-diffusion. Br J Pharmacol 1992;105:708-14.
20. Holzer P, Pabst MA, Lippe IT, et al. Afferent nerve-mediated protection against deep mucosal damage in the rat stomach. Gastroenterology 1990;98:838-48.
21. Banick PD, Chen Q, Xu YA, et al. Nitric oxide inhibits neutrophil beta 2 integrin function by inhibiting membrane-associated cyclic GMP synthesis. J Cell Physiol 1997;172:12-24.
22. Davenpeck KL, Gauthier TW, Lefer AM. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology 1994;107: 1050-8.
23. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 1991;88:4651-5.
24. Grisham MB, Granger DN, Lefer DJ. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radic Biol Med 1998;25:404-33.
25. Kanwar S, Wallace JL, Befus D, et al. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. Am J Physiol 1994;266:G222-9.
26. Obermeier F, Gross V, Scholmerich J, et al. Interleukin-1 production by mouse macrophages is regulated in a feedback fashion by nitric oxide. J Leukoc Biol 1999;66:829-36.
27. Huang FP, Niedbala W, Wei XQ, et al. Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur J Immunol 1998;28:4062-70.
28. Gobert AP, Mersey BD, Cheng Y, et al. Cutting edge: urease release by Helicobacter pylori stimulates macrophage inducible nitric oxide synthase. J Immunol 2002;168:6002-6.
29. Gobert AP, Cheng Y, Wang JY, et al. Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J Immunol 2002;168:4692-700.
30. Wilson KT, Ramanujam KS, Mobley HLT, et al. Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line. Gastroenterology 1996; 111:1524-33.
31. Sato E, Simpson KL, Grisham MB, et al. Reactive nitrogen and oxygen species attenuate interleukin-8-induced neutrophil chemotactic activity in vitro. J Biol Chem 2000;275:10826-30.
32. Sato E, Simpson KL, Grisham MB, et al. Effects of reactive oxygen and nitrogen metabolites on MCP-1-induced monocyte chemotactic activity in vitro. Am J Physiol 1999;277:L543-9.
33. Adachi R, Matsui S, Kinoshita M, et al. Nitric oxide induces chemotaxis of neutrophil-like HL-60 cells and translocation of cofilin to plasma membranes. Int J Immunopharmacol 2000;22: 855-64.
34. Bani D, Masini E, Bello MG, et al. Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells. Cancer Res 1995;55:5272-5.
35. Jenkins DC, Charles IG, Thomsen LL, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A 1995;92:4392-6.
36. Messmer UK, Ankarcrona M, Nicotera P, et al. p53 expression in nitric oxide-induced apoptosis. FEBS Lett 1994;355:23-6.
37. Radi R, Beckman JS, Bush KM, et al. Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991;266:4244-50.
38. Fukuo K, Inoue T, Morimoto S, et al. Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells: a possible mechanism of neovascularization in atherosclerotic plaques. J Clin Invest 1995;95: 669-76.
39. Wink DA, Kasprzak KS, Maragos CM, et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991;254:1001-3.
40. Nguyen T, Brunson D, Crespi CL, et al. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci U S A 1992;89:3030-4.
41. Liu RH, Hotchkiss JH. Potential genotoxicity of chronically elevated nitric oxide: a review. Mutat Res 1995;339:73-89.
42. Forstermann U, Closs EI, Pollock JS, et al. Nitric oxide synthase isozymes: characterization, purification, molecular cloning, and functions. Hypertension 1994;23:1121-31.
43. Kurose I, Ebinuma H, Higuchi H, et al. Nitric oxide mediates mitochondrial dysfunction in hepatoma cells induced by non-activated Kupffer cells: evidence implicating ICAM-1-dependent process. J Gastroenterol Hepatol 1995;10(suppl 1):S68-71.
44. Middleton SJ, Shorthouse M, Hunter JO. Increased nitric oxide synthesis in ulcerative colitis. Lancet 1993;341:465-6.
45. Boughton-Smith NK, Evans SM, Hawkey CJ, et al. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 1993;342:338-40.
46. Rachmilewitz D, Stamler JS, Bachwich D, et al. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 1995;36:718-23.
47. Lundberg JO, Hellstrom PM, Lundberg JM, et al. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1994; 344:1673-4.
48. Ljung T, Herulf M, Beijer E, et al. Rectal nitric oxide assessment in children with Crohn disease and ulcerative colitis: indicator of ileocaecal and colorectal affection. Scand J Gastroenterol 2001; 36:1073-6.
49. Ljung T, Beijer E, Herulf M, et al. Increased rectal nitric oxide in children with active inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2002;34:302-6.
50. Perner A, Nordgaard I, Matzen P, et al. Colonic production of nitric oxide gas in ulcerative colitis, collagenous colitis and un-inflamed bowel. Scand J Gastroenterol 2002;37:183-8.
51. Iwashita E. Greatly increased mucosal nitric oxide in ulcerative colitis determined in situ by a novel nitric oxide-selective micro-electrode. J Gastroenterol Hepatol 1998;13:391-5.
52. Goggins MG, Shah SA, Goh J, et al. Increased urinary nitrite, a marker of nitric oxide, in active inflammatory bowel disease. Mediators Inflamm 2001;10:69-73.
53. Godkin AJ, De Belder AJ, Villa L, et al. Expression of nitric oxide synthase in ulcerative colitis. Eur J Clin Invest 1996;26: 867-72.
54. Leonard N, Bishop AE, Polak JM, et al. Expression of nitric oxide synthase in inflammatory bowel disease is not affected by corticosteroid treatment. J Clin Pathol 1998;51:750-3.
55. Dijkstra G, Zandvoort AJ, Kobold AC, et al. Increased expression of inducible nitric oxide synthase in circulating monocytes from patients with active inflammatory bowel disease. Scand J Gastroenterol 2002;37:546-54.
56. Singer II, Kawka DW, Scott S, et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996;111: 871-85.
57. Roberts PJ, Riley GP, Morgan K, et al. The physiological expression of inducible nitric oxide synthase (iNOS) in the human colon. J Clin Pathol 2001;54:293-7.
58. Vento P, Kiviluoto T, Jarvinen HJ, et al. Changes in distribution of three isoforms of nitric oxide synthase in ulcerative colitis. Scand J Gastroenterol 2001;36:180-9.
59. Kolios G, Rooney N, Murphy CT, et al. Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines. Gut 1998;43: 56-63.
60. Kimura H, Hokari R, Miura S, et al. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut 1998;42:180-7.
61. Rachmilewitz D, Eliakim R, Ackerman Z, et al. Direct determination of colonic nitric oxide level: a sensitive marker of disease activity in ulcerative colitis. Am J Gastroenterol 1998;93:409-12.
62. Vento P, Kiviluoto T, Jarvinen HJ, et al. Expression of inducible and endothelial nitric oxide synthases in pouchitis. Inflamm Bowel Dis 2001;7:120-7.
63. Rees DC, Satsangi J, Cornelissen PL, et al. Are serum concentrations of nitric oxide metabolites useful for predicting the clinical outcome of severe ulcerative colitis? Eur J Gastroenterol Hepatol 1995;7:227-30.
64. Koek GH, Verleden GM, Evenepoel P, et al. Activity related increase of exhaled nitric oxide in Crohn's disease and ulcerative colitis: a manifestation of systemic involvement? Respir Med 2002;96:530-5.
65. Guihot G, Guimbaud R, Bertrand V, et al. Inducible nitric oxide synthase activity in colon biopsies from inflammatory areas: correlation with inflammation intensity in patients with ulcerative colitis but not with Crohn's disease. Amino Acids 2000;18: 229-37.
66. Kimura H, Miura S, Shigematsu T, et al. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig Dis Sci 1997;42:1047-54.
67. Miller MJS, Thompson JH, Zhang X-J, et al. Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis. Gastroenterology 1995;109:1475-83.
68. Rachmilewitz D, Stamler JS, Karmeli F, et al. Peroxynitrite-induced rat colitis: a new model of colonic inflammation. Gastroenterology 1993;105:1681-8.
69. Ribbons KA, Zhang XJ, Thompson JH, et al. Potential role of nitric oxide in a model of chronic colitis in rhesus macaques. Gastroenterology 1995;108:705-11.
70. Miller MJ, Sadowska-Krowicka H, Chotinaruemol S, et al. Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther 1993;264:11-6.
71. Grisham MB, Specian RD, Zimmerman TE. Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. J Pharmacol Exp Ther 1994;271:1114-21.
72. Rachmilewitz D, Karmeli F, Okon E. Sulfhydryl blocker-induced rat colonic inflammation is ameliorated by inhibition of nitric oxide synthase. Gastroenterology 1995;109:98-106.
73. Rachmilewitz D, Karmeli F, Okon E, et al. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 1995;37:247-55.
74. Aiko S, Grisham MB. Spontaneous intestinal inflammation and nitric oxide metabolism in HLA-B27 transgenic rats. Gastroenterology 1995;109:142-50.
75. Hogaboam CM, Jacobson K, Collins SM, et al. The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am J Physiol 1995;268:G673-84.
76. Kiss J, Lamarque D, Delchier JC, et al. Time-dependent actions of nitric oxide synthase inhibition on colonic inflammation induced by trinitrobenzene sulphonic acid in rats. Eur J Pharmacol 1997;336:219-24.
77. Kankuri E, Vaali K, Knowles RG, et al. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine. J Pharmacol Exp Ther 2001;298:1128-32.
78. Menchen LA, Colon AL, Moro MA, et al. N-(3-(amino-methyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats. Life Sci 2001;69:479-91.
79. Yamaguchi T, Yoshida N, Ichiishi E, et al. Differing effects of two nitric oxide synthase inhibitors on experimental colitis. Hepatogastroenterology 2001;48:118-22.
80. Nakamura H, Tsukada H, Oya M, et al. Aminoguanidine has both an antiinflammatory effect on experimental colitis and a proliferative effect on colonic mucosal cells. Scand J Gastroenterol 1999;34:1117-22.
81. Obermeier F, Kojouharoff G, Hans W, et al. Interferon-gamma (IFN-gamma)- and tumor necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol 1999;116: 238-45.
82. Zingarelli B, Cuzzocrea S, Szabo C, et al. Mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxy-nitrite scavenger, reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J Pharmacol Exp Ther 1998;287: 1048-55.
83. Asfaha S, MacNaughton WK, Appleyard CB, et al. Persistent epithelial dysfunction and bacterial translocation after resolution of intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2001;281:G635-44.
84. Yue G, Lai PS, Yin K, et al. Colon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production. J Pharmacol Exp Ther 2001:297:915-25.
85. Hosoi T, Goto H, Arisawa T, et al. Role of nitric oxide synthase inhibitor in experimental colitis induced by 2,4,6-trinitrobenzene sulphonic acid in rats. Clin Exp Pharmacol Physiol 2001;28: 9-12.
86. Ribbons KA, Currie MG, Connor JR, et al. The effect of inhibitors of inducible nitric oxide synthase on chronic colitis in the rhesus monkey. J Pharmacol Exp Ther 1997;280:1008-15.
87. Dikopoulos N, Nussler AK, Liptay S, et al. Inhibition of nitric oxide synthesis by aminoguanidine increases intestinal damage in the acute phase of rat TNB-colitis. Eur J Clin Invest 2001;31: 234-9.
88. Yoshida Y, Iwai A, Itoh K, et al. Role of inducible nitric oxide synthase in dextran sulphate sodium-induced colitis. Aliment Pharmacol Ther 2000;14(suppl 1):26-32.
89. Armstrong AM, Campbell GR, Gannon C, et al. Oral administration of inducible nitric oxide synthase inhibitors reduces nitric oxide synthesis but has no effect on the severity of experimental colitis. Scand J Gastroenterol 2000;35:832-8.
90. Salas A, Gironella M, Soriano A, et al. Nitric oxide supplementation ameliorates dextran sulfate sodium-induced colitis in mice. Lab Invest 2002;82:597-607.
91. Fiorucci S, Antonelli E, Distrutti E, et al. NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice. Proc Natl Acad Sci U S A 2002;99:15770-5.
92. McCafferty DM, Mudgett JS, Swain MG, et al. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 1997;112:1022-7.
93. McCafferty DM, Miampamba M, Sihota E, et al. Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice. Gut 1999;45:864-73.
94. McCafferty DM, Sihota E, Muscara M, et al. Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice. Am J Physiol Gastrointest Liver Physiol 2000;279:G90-9.
95. Hokari R, Kato S, Matsuzaki K, et al. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis. Free Radic Biol Med 2001;31:153-63.
96. Krieglstein CF, Cerwinka WH, Laroux FS, et al. Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J Exp Med 2001;194:1207-18.
97. Binion DG, Fu S, Ramanujam KS, et al. iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion. Am J Physiol 1998;275:G592-603.
98. Binion DG, Rafiee P, Ramanujam KS, et al. Deficient iNOS in inflammatory bowel disease intestinal microvascular endothelial cells results in increased leukocyte adhesion. Free Radic Biol Med 2000;29:881-8.
99. Rafiee P, Johnson CP, Li MS, et al. Cyclosporine A enhances leukocyte binding by human intestinal microvascular endothelial cells through inhibition of p38 MAPK and iNOS: paradoxical proinflammatory effect on the microvascular endothelium. J Biol Chem 2002;277:35605-15.
100. Pegg AE, McCann PP. Polyamine metabolism and function. Am J Physiol 1982;243:C212-21.
101. Marton LJ, Pegg AE. Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 1995;35:55-91.
102. Thomas T, Thomas TJ. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 2001;58:244-58.
103. Ray RM, McCormack SA, Johnson LR. Polyamine depletion arrests growth of IEC-6 and Caco-2 cells by different mechanisms. Am J Physiol Gastrointest Liver Physiol 2001;281:G37-43.
104. Li L, Rao JN, Bass BL, et al. NF-κB activation and susceptibility to apoptosis after polyamine depletion in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2001;280:G992-1004.
105. Zhang M, Caragine T, Wang H, et al. Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counterregulatory mechanism that restrains the immune response. J Exp Med 1997;185:1759-68.
106. Hasko G, Kuhel DG, Marton A, et al. Spermine differentially regulates the production of interleukin-12 p40 and interleukin-10 and suppresses the release of the T helper 1 cytokine interferon-gamma. Shock 2000;14:144-9.
107. Quan CP, Roux C, Pillot J, et al. Delineation between T and B suppressive molecules from human seminal plasma: II. Spermine is the major suppressor of T-lymphocytes in vitro. Am J Reprod Immunol 1990;22:64-9.
108. Ferrante A. Inhibition of human neutrophil locomotion by the polyamine oxidase-polyamine system. Immunology 1985;54: 785-90.
109. Jenkinson CP, Grody WW, Cederbaum SD. Comparative properties of arginases. Comp Biochem Physiol B Biochem Mol Biol 1996;114:107-32.
110. Morris SM Jr, Bhamidipati D, Kepka-Lenhart D. Human type II arginase: sequence analysis and tissue-specific expression. Gene 1997;193:157-61.
111. Wei LH, Morris SM Jr, Cederbaum SD, et al. Induction of arginase II in human caco-2 tumor cells by cyclic AMP. Arch Biochem Biophys 2000;374:255-60.
112. Sonoki T, Nagasaki A, Gotoh T, et al. Coinduction of nitric-oxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissues in vivo by lipopolysaccharide. J Biol Chem 1997; 272:3689-93.
113. Morris SM Jr, Kepka-Lenhart D, Chen LC. Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. Am J Physiol 1998;275:E740-7.
114. Wei LH, Jacobs AT, Morris SM Jr, et al. IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells. Am J Physiol Cell Physiol 2000; 279:C248-56.
115. Kocna P, Fric P, Zavoral M, et al. Arginase activity determination: a marker of large bowel mucosa proliferation. Eur J Clin Chem Clin Biochem 1996;34:619-23.
116. Ricci G, Stabellini G, Bersani G, et al. Ornithine decarboxylase in colonic mucosa from patients with moderate or severe Crohn's disease and ulcerative colitis. Eur J Gastroenterol Hepatol 1999; 11:903-4.
117. Obayashi M, Matsui-Yuasa I, Matsumoto T, et al. Polyamine metabolism in colonic mucosa from patients with ulcerative colitis. Am J Gastroenterol 1992;87:736-40.
118. Pillai RB, Tolia V, Rabah R, et al. Increased colonic ornithine decarboxylase activity in inflammatory bowel disease in children. Dig Dis Sci 1999;44:1565-70.
119. Raul F, Galluser M, Schleiffer R, et al. Beneficial effects of L-arginine on intestinal epithelial restitution after ischemic damage in rats. Digestion 1995;56:400-5.
120. Akisu M, Ozmen D, Baka M, et al. Protective effect of dietary supplementation with L-arginine and L-carnitine on hypoxia/reoxygenation-induced necrotizing enterocolitis in young mice. Biol Neonate 2002;81:260-5.
121. Seven A, Seymen O, Inci F, et al. Evaluation of oxidative stress in experimental colitis: effects of L-arginine-nitric oxide pathway manipulation. J Toxicol Environ Health A 2000;61:167-76.
122. Mane J, Fernandez-Banares F, Ojanguren I, et al. Effect of L-arginine on the course of experimental colitis. Clin Nutr 2001; 20:415-22.
123. Gobert AP, Cheng Y, Mersey BD, et al. Protective role of arginase in Citrobacter rodentium colitis. Gastroenterology 2002; 122:A44.
124. Boucher JL, Moali C, Tenu JP. Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol Life Sci 1999;55:1015-28.
125. Moali C, Boucher JL, Sari MA, et al. Substrate specificity of NO synthases: detailed comparison of L-arginine, homo-L-arginine, their N omega-hydroxy derivatives, and N omega-hydroxynor-L-arginine. Biochemistry 1998;37:10453-60.
126. Oudkerk Pool M, Bouma G, Visser JJ, et al. Serum nitrate levels in ulcerative colitis and Crohn's disease. Scand J Gastroenterol 1995;30:784-8.